What are the Factors that Could Contribute to the Lower Risk of Major Bleeding with Bivalirudin Compared with Unfractionated Heparin for Percutaneous Coronary Intervention?
The benefit of bivalirudin in reduction of major bleeding compared with unfractionated heparin in percutaneous coronary intervention remains a matter of on-going debate. Multiple metaanalyses had illustrated a substantial reduction in the risk of major bleeding with bivalirudin [1,2,3]. However, we...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Barcaray International
2016-01-01
|
| Series: | International Cardiovascular Forum Journal |
| Subjects: | |
| Online Access: | http://icfjournal.org/index.php/icfj/article/view/359/MAHMOUD%2010.17987%3Aicfj.v9i0.359 |